AOC3 and obesity disorder: The clinical impact of low sRAGE levels for future prognosis of metabolically healthy obese subjects, and potential interaction in RAGE/VAP-1/SSAO axis in obesity-associated pathology remain to be elucidated in longitudinal studies.